Nicholas Company, Inc. Astrazeneca PLC Transaction History
Nicholas Company, Inc.
- $5.89 Billion
- Q2 2024
A detailed history of Nicholas Company, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Nicholas Company, Inc. holds 995,625 shares of AZN stock, worth $77.6 Million. This represents 1.32% of its overall portfolio holdings.
Number of Shares
995,625
Previous 995,625
-0.0%
Holding current value
$77.6 Million
Previous $67.5 Million
15.11%
% of portfolio
1.32%
Previous 1.14%
Shares
12 transactions
Others Institutions Holding AZN
# of Institutions
1,334Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.06 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.32 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.16 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$2.86 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.37 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $242B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...